28 February 2027
FDA PDUFA target action date for VYONDYS 53 (golodirsen), a NDA from Sarepta Therapeutics. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
FDA PDUFA Decision Dates calendar